Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles
Brain Research · 2024-10 · 1840 · 149045
DOI: 10.1016/j.brainres.2024.149045 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Research, 2024-10. Verfasst von Soo Yeon Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Pediatrics, Penn State College of Medicine, Hershey, PA, USA. Hauptthemen laut MEDLINE: Ferroptosis, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, Four Diamonds, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Ferroptosis, an iron-dependent form of non-apoptotic regulated cell death, is induced by the accumulation of lipid peroxides on cellular membranes. Over the past decade, ferroptosis has emerged as a crucial process implicated in various physiological and pathological systems. Positioned as an alternative modality of cell death, ferroptosis holds promise for eliminating cancer cells that have developed resistance to apoptosis induced by conventional therapeutics. This has led to a growing interest in leveraging ferroptosis for cancer therapy across diverse malignancies. Gliomas are tumors arising from glial or precursor cells, with glioblastoma (GBM) being the most common malignant primary brain tumor that is associated with a dismal prognosis. This review provides a summary of recent advancements in the exploration of ferroptosis-sensitizing methods, with a specific focus on their potential application in enhancing the treatment of gliomas. In addition to summarizing the therapeutic potential, this review also discusses the intricate interplay of ferroptosis and its potential tumor-promoting roles within gliomas. Recognizing these dual roles is essential, as they could potentially complicate the therapeutic benefits of ferroptosis. Exploring strategies aimed at circumventing these tumor-promoting roles could enhance the overall therapeutic efficacy of ferroptosis in the context of glioma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology and Oncology, Department of Pediatrics, Penn State College of Medicine, Hershey, PA, USA.
- Division of Hematology and Oncology, Department of Pediatrics, Penn State College of Medicine, Hershey, PA, USA; Medical Scientist Training Program, Penn State College of Medicine, Hershey, PA, USA.
- Division of Hematology and Oncology, Department of Pediatrics, Penn State College of Medicine, Hershey, PA, USA; Penn State Cancer Institute, Penn State College of Medicine, Hershey, PA, USA; Department of Biochemistry…
Förderung
- NINDS NIH HHS
- Four Diamonds
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Yeon Kim, S., Tang, M., Lu, T., Chih, S. Y., & Li, W. (2024). Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles. Brain Research, 1840, 149045. https://doi.org/10.1016/j.brainres.2024.149045
Vancouver
Yeon Kim S, Tang M, Lu T, Chih SY, Li W. Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles. Brain Research. 2024;1840:149045. doi:10.1016/j.brainres.2024.149045
BibTeX
@article{YeonKim2024,
author = {Yeon Kim, Soo and Tang, Miaolu and Lu, Tong and Chih, Stephen Y and Li, Wei},
title = {Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles},
journal = {Brain Research},
year = {2024},
volume = {1840},
pages = {149045},
doi = {10.1016/j.brainres.2024.149045}
}
EUVIMED